Emilio Hirsch is Professor of Experimental Biology in the Medical School, University of Torino since 2005. He has authored more than 200 scientific publications that received more than 18000 citations. He is an internationally recognized scientist, elected member of the European Molecular Biology Organization (EMBO), Fellow of the International Society of Heart Research (ISHR) and receiver of the American Association for Cancer Research (AACR) innovator prize. He contributed seminal work in the
characterization of key signal transduction enzymes named PI3Ks with publications in Science, Nature and Cell. He was involved in the identification of the first PI3K inhibitors for the treatment of cancer and
inflammation. His experience in drug discovery was seminal to the design of Kither’s KITCL27. He discovered the scaffolding function of PI3Kgamma that led to the design of Kither’s KIT2014.